At the doses used in retatrutide, however, the net metabolic effect in combination with GLP-1 and GIP co-activation appears to increase basal energy expenditure and accelerate lipolysis, particularly visceral fat
There is also great potential for GLP-1s in managing risk of obstructive sleep apnea during the perimenopausal period
It's worth noting that this is a community-created nickname, not an official scientific or pharmaceutical term
Indications and Usage Ozempic (semaglutide) tablets 4 mg or 9 mg and Rybelsus (semaglutide) tablets 7 mg or 14 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events Important Safety Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Not for human or veterinary use, ingestion, injection, or any in-vivo administration
